Related references
Note: Only part of the references are listed.Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis
Amiko M. Uchida et al.
ALLERGY (2022)
Eosinophils in Health and Disease: A State-of-the-Art Review
Michael E. Wechsler et al.
MAYO CLINIC PROCEEDINGS (2021)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Targeted Therapies for Eosinophilic Gastrointestinal Disorders
Alfredo J. Lucendo et al.
BIODRUGS (2020)
Cellular context of IL-33 expression dictates impact on anti-helminth immunity
Li-Yin Hung et al.
SCIENCE IMMUNOLOGY (2020)
Establishing a many-cytokine signature via multivariate anomaly detection
K. Dingle et al.
SCIENTIFIC REPORTS (2019)
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2019)
Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis
Justin T. Schwartz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
Evan S. Dellon et al.
GASTROENTEROLOGY (2018)
IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis
J. Travers et al.
SCIENTIFIC REPORTS (2017)
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis
David W. Morris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
Miho Akimoto et al.
NATURE COMMUNICATIONS (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells
Sarah Mombelli et al.
SCIENTIFIC REPORTS (2015)
The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders
Fanny Legrand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Eosinophil Granule Proteins: Form and Function
K. Ravi Acharya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Increased serum levels of interleukin 33 in patients with atopic dermatitis
Risa Tamagawa-Mineoka et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The mRNA level of Charcot-Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro
Tai-An Lin et al.
BIOMARKERS (2010)
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Tatjana Pecaric-Petkovic et al.
BLOOD (2009)
CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation
Zoulfia Allakhverdi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
W. Brett Cherry et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Role of the chemokines RANTES, monocyte chemotactic proteins-3 and-4, and eotaxins-1 and-2 in childhood asthma
E Rojas-Ramos et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease
B Bishop et al.
JOURNAL OF IMMUNOLOGY (2003)